In early February, Amgen released financial results for the 4th quarter of 2024, which I was eagerly awaiting. In addition to demonstrating efficacy in the treatment of nasal polyps in Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback